| Filed On | Filing |
|---|---|
| 08 Aug 2024 | 8-K/A: Other Events |
| 13 Jan 2020 |
8-K/A: Regulation FD Disclosure; Other Events
On January 13, 2020, Aeglea BioTherapeutics, Inc. (the “Company”) issued a press release announcing it has filed a Clinical Trial Application (“CTA”) with the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (“MHRA”) ... |
Loading...